APRIL and sTACI could be predictors of multiorgan dysfunction syndrome in sepsis

References

• Stoller J, Halpin L, Weis M, et al. Epidemiology of severe sepsis: 2008-2012. J Crit Care 2016;31:58–62.
   PubMed Web of Science ®Google Scholar
• Maye FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014;35:513–20.
   Google Scholar
• Esper AM, Martin GS. Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care 2009;13(1):120.
   PubMed Web of Science ®Google Scholar
• Charles P-E, Gibot S. Predicting outcome in patients with sepsis: new biomarkers for old expectations. Crit Care 2014;18:108.
   PubMed Web of Science ®Google Scholar
• Skirecki T, Borkowska-Zielińska U, Złotorowicz M, Hoser G. Sepsis immunopathology: Perspectives of monitoring and modulation of the immune disturbances. Arch. Immunol. Ther. Exp. (Warsz) 2012;60:123–35.
   PubMed Web of Science ®Google Scholar
• Cho S, Choi J. Biomarkers of Sepsis. Infect Chemother 2014;46:1–12.
   PubMedGoogle Scholar
• Deutschman CS, Tracey KJ. Sepsis: Current dogma and new perspectives. Immunity 2014;40:463–75.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014;5:36–44.
   PubMed Web of Science ®Google Scholar
• Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009;9:491–502.
   PubMed Web of Science ®Google Scholar
• Vincent FB, Saulep-Easton D, Figgett WA, et al. The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 2013;24:203–15.
   PubMed Web of Science ®Google Scholar
• Matthes T, Dunand-sauthier I, Krause K. Production of the plasma-cell survival factor APRIL peaks in myeloid precursor cells from human bone marrow Production of the plasma-cell survival factor APRIL peaks in myeloid precursor cells from human bone marrow. Blood 2011;118:1838–45.
   PubMed Web of Science ®Google Scholar
• Koyama T, Tsukamoto H, Miyagi Y, et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis 2005;64:1065–7.
   PubMed Web of Science ®Google Scholar
• Vallerskog T, Heimbürger M, Gunnarsson I, et al. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 2006;8:R167.
   PubMed Web of Science ®Google Scholar
• Lemancewicz D, Bolkun L, Jablonska E, et al. Evaluation of TNF superfamily molecules in multiple myeloma patients: Correlation with biological and clinical features. Leuk Res 2013;37:1089–93.
   PubMed Web of Science ®Google Scholar
• Roderburg C, Koch A, Tacke F, et al. Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. J Crit Care 2013;28(5):882.e1–11.
   PubMed Web of Science ®Google Scholar
• Goenka R, Scholz JL, Sindhava VJ, Cancro MP. New roles for the BLyS/BAFF family in antigen-experienced B cell niches. Cytokine Growth Factor Rev 2014;25:107–13.
   PubMed Web of Science ®Google Scholar
• Salzer U, Chapel HM, Webster AD, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005;37:820–828.
   PubMed Web of Science ®Google Scholar
• Hoffmann FS, Kuhn P-H, Laurent SA, et al. The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity. J Immunol 2014;194:542–52.
   PubMed Web of Science ®Google Scholar
• Lobo SMA, Lobo FRM, Bota DP. C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill Patients #. Chest 2003;123:2043–9.
   PubMed Web of Science ®Google Scholar
• Suberviola B, Castellanos-Ortega A, González-Castro A, et al. Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock. Med Intensiva (English Ed) 2012;36:177–84.
   PubMed Web of Science ®Google Scholar
• Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011;26:54–64.
   PubMed Web of Science ®Google Scholar
• Jensen JU, Heslet L, Jensen TH et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596–602.
   PubMed Web of Science ®Google Scholar
• Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66:33–40.
   Web of Science ®Google Scholar
• Pierrakos C, Vincent J-L. Sepsis biomarkers: a review. Crit Care 2010;14:R15.
   PubMed Web of Science ®Google Scholar
• Wang B, Chen G, Cao Y. Correlation of lactate/albumin ratio level to organ failure and mortality in severe sepsis and septic shock. J Crit Care 2015;30(2):271–5.
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013;41:580–637.
   PubMed Web of Science ®Google Scholar
• Rossaint J, Zarbock A. Pathogenesis of multiple organ failure in spesis. Crircal Reviews in Immunology No Title. 2015;35(4):277–91.
   PubMed Web of Science ®Google Scholar
• Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. 2008;26:711–5.
   Google Scholar
• Gomes H, Kellum JA. Sepsis induced acute kidney injury. Curr Opin Crit Care 2016;22(6):546–53.
   PubMed Web of Science ®Google Scholar
• Zampieri FG, Park M, Machado FS, et al. Sepsis-associated encephalopathy: not just delirium. Clinics 2011;66(10):1825–31.
   PubMed Web of Science ®Google Scholar
• Adam N, Kandelman S, Mantz J, et al. Sepsis-induced brain dysfunction. Expert Rev Anti Infect Ther 2013;11(2):211–21.
   PubMed Web of Science ®Google Scholar
• Nesseler N, Launey Y, Aninat C, et al. Clinical review: The liver in sepsis. Criti Care 2012;16:235.
   PubMed Web of Science ®Google Scholar
• de Pablo R, Monserrat J, Prieto A, et al. Role of Circulating Lymphocytes in Patients with Sepsis. Biomed Research International 2014;671087.
   PubMed Web of Science ®Google Scholar
• Kelly-Scumpia KM, Scumpia PO, Weinstein JS, et al. B cells enhance early innate immune responses during bacterial sepsis. J Exp Med 2011;208:1673–82.
   PubMed Web of Science ®Google Scholar
• Vaughan AT, Roghanian A, Cragg MS. B cells–masters of the immunoverse. Int J Biochem Cell Biol 2011;43:280–5.
   PubMed Web of Science ®Google Scholar
• Anolik JH, Looney RJ, Lund FE, et al. Insights into the heterogeneity of human B cells: Diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res 2009;45:144–58.
   PubMed Web of Science ®Google Scholar
• Bolkun L, Lemancewicz D, Jablonska E, et al. BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma. Ann Hematol 2014;93:635–44.
   PubMed Web of Science ®Google Scholar
• Treamtrakanpon W, Tantivitayakul P, Benjachat T, et al. APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis. Arthritis Res Ther 2012;14:R252.
   PubMed Web of Science ®Google Scholar
• Salazar-Camarena DC, Ortiz-Lazareno PC, Cruz A, et al. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 2016;25(6):582–92.
   PubMed Web of Science ®Google Scholar
• Haiat S, Billard C, Quiney C, et al. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 2006;118:281–92.
   PubMed Web of Science ®Google Scholar
• Warnatz K, Salzer U, Rizzi M, et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009;106:13945–50.
   PubMed Web of Science ®Google Scholar
• Yu G, Boone T, Delaney J, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol 2000;1:252–6.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013;13:862–74.
   PubMed Web of Science ®Google Scholar
• Chen X, Yin Y, Zheng J. Sepsis and immune response. World J Emerg Med 2011;2(2):88–92.
   PubMedGoogle Scholar
• Huttunen R, Aittoniemi J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect 2011;63:407–19.
   PubMed Web of Science ®Google Scholar
• Exline MC, Crouser E. Mitochondrial Mechanisms of Sepsis-Induced Organ failure. Front Biosi 2014;13:5030–41.
   Google Scholar
• Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis: a review. Shock 2002;18(3):197–211.
   PubMed Web of Science ®Google Scholar
• Hofer S, Brenner T, Bopp C, et al. Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 2009;13:R93.
   PubMed Web of Science ®Google Scholar
• Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 2014;5:45–56.
   PubMed Web of Science ®Google Scholar
• Opal SM, Rubenfeld GD, Poll T Van Der, et al. Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801–10.
   PubMed Web of Science ®Google Scholar